EV/EBITDA
0.29
0.000.00%
Thu, 06 Feb 2025 14:30:00 GMT
Summary
- As of February 8, 2025, NAVB EV/EBITDA is 0.29, unchanged from the previous trading day.
- Over the past year, NAVB EV/EBITDA has increased by +0.43 (+307.14%).
- NAVB EV/EBITDA is now -99.52% below its all-time high of 60.91.
Performance
NAVB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NAVB EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | 0.0% | 0.0% | 0.0% |
| 3 m3 months | 0.0% | -1.6% | -80.0% |
| 6 m6 months | +3.6% | -3.6% | -90.0% |
| ytdytd | 0.0% | 0.0% | 0.0% |
| 1 y1 year | +307.1% | -307.9% | -99.7% |
| 5 y5 years | +115.5% | -112.8% | -100.0% |
NAVB EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | 0.28 | +3.6% | |
| 3 m | 3-month | 0.29 | at high | 0.28 | +3.6% |
| 6 m | 6-month | 0.29 | at high | 0.27 | +7.4% |
| 1 y | 1-year | 0.29 | at high | -0.27 | +207.4% |
| 3 y | 3-year | 0.29 | at high | -2.88 | +110.1% |
| 5 y | 5-year | 0.29 | at high | -11.66 | +102.5% |
| alltime | all time | 60.91 | -99.5% | -121.34 | +100.2% |
Navidea Biopharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.29(0.0%) |
| 2024 | 0.29(-187.9%) |
| 2023 | -0.33(-36.5%) |
| 2022 | -0.52(-78.2%) |
| 2021 | -2.38(-55.6%) |
| 2020 | -5.36(+139.3%) |
| 2019 | -2.24(+37.4%) |
| 2018 | -1.63(-62.2%) |
| 2017 | -4.31(-74.0%) |
| 2016 | -16.56(+13.4%) |
| 2015 | -14.60(+26.8%) |
| 2014 | -11.51(+58.5%) |
| 2013 | -7.26(-37.0%) |
| 2012 | -11.53(+25.9%) |
| 2011 | -9.16(-47.4%) |
| 2010 | -17.40(-75.1%) |
| 2009 | -69.77(+208.3%) |
| Date | Value |
|---|---|
| 2008 | -22.63(+3277.6%) |
| 2007 | -0.67(-91.9%) |
| 2006 | -8.28(+22.3%) |
| 2005 | -6.77(-74.5%) |
| 2004 | -26.58(+50.6%) |
| 2003 | -17.65(+828.9%) |
| 2002 | -1.90(-116.2%) |
| 2001 | 11.73(+193.3%) |
| 2000 | 4.00(-969.6%) |
| 1999 | -0.46(-24.6%) |
| 1998 | -0.61(-87.1%) |
| 1997 | -4.74(-65.3%) |
| 1996 | -13.66(+14.0%) |
| 1995 | -11.98(+2504.3%) |
| 1994 | -0.46(-92.7%) |
| 1993 | -6.29(-61.7%) |
| 1992 | -16.43 |
FAQ
- What is Navidea Biopharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Navidea Biopharmaceuticals?
- What is NAVB EV/EBITDA year-to-date change?
- What is Navidea Biopharmaceuticals EV/EBITDA year-on-year change?
What is Navidea Biopharmaceuticals EV/EBITDA?
The current EV/EBITDA of NAVB is 0.29
What is the all time high EV/EBITDA for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high EV/EBITDA is 60.91
What is NAVB EV/EBITDA year-to-date change?
Navidea Biopharmaceuticals EV/EBITDA has changed by 0.00 (0.00%) since the beginning of the year
What is Navidea Biopharmaceuticals EV/EBITDA year-on-year change?
Over the past year, NAVB EV/EBITDA has changed by +0.43 (+307.14%)